Popular filter options for substance abuse trials
Opioid Use Disorder Clinical Trials
View 30 Opioid Use Disorder medical studies.
Behavioral Intervention
Peer-Delivered Behavioral Activation for Opioid Addiction
This trial is testing a new behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minority individuals living with opioid use disorder (OUD) in Baltimore, Maryland.
Behavioural Intervention
Wraparound Intervention for Families with Substance Use Disorders
This trial is testing whether the Wraparound intervention can help families with substance use disorders who have children placed outside the home or are at risk of such placement. The investigators hypothesize that families receiving Wraparound will have better parenting and family functioning outcomes, child safety, permanency, and well-being, and parental recovery than families receiving treatment as usual.
Behavioural Intervention
CBD for Opioid Use Disorder
This trial will test if CBD can help reduce craving and anxiety in people abstaining from heroin. Brain scans will be taken before and after CBD administration to see how it affects neural circuits and transmitters.
Substance Use Disorder Clinical Trials
View 23 Substance Use Disorder medical studies.
Behavioural Intervention
Wraparound Intervention for Families with Substance Use Disorders
This trial is testing whether the Wraparound intervention can help families with substance use disorders who have children placed outside the home or are at risk of such placement. The investigators hypothesize that families receiving Wraparound will have better parenting and family functioning outcomes, child safety, permanency, and well-being, and parental recovery than families receiving treatment as usual.
Behavioral Intervention
Family Communication Intervention for Preventing Adolescent Substance Use
This trial is testing a new substance misuse prevention intervention that is based on family communication. The goal is to increase the quality time that parents spend with their children, talking about the harms associated with substance use, in order to prevent the misuse of substances among their children as they enter adolescence.
Behavioral Intervention
First Face Training for Mental Health Support in Tribal Communities
This trial will test a program that trains Tribal community members to help people with mental health needs, to see if it works. Participants will be surveyed before and after the program.
Substance Abuse Clinical Trials With No Placebo
View 98 substance abuse medical studies that do not have a placebo group.
Behavioral Intervention
Peer-Delivered Behavioral Activation for Opioid Addiction
This trial is testing a new behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minority individuals living with opioid use disorder (OUD) in Baltimore, Maryland.
Behavioural Intervention
Wraparound Intervention for Families with Substance Use Disorders
This trial is testing whether the Wraparound intervention can help families with substance use disorders who have children placed outside the home or are at risk of such placement. The investigators hypothesize that families receiving Wraparound will have better parenting and family functioning outcomes, child safety, permanency, and well-being, and parental recovery than families receiving treatment as usual.
View More Substance Abuse Trials
See another 72 medical studies focused on substance abuse.
Frequently Asked Questions
Introduction to substance abuse
What are the top hospitals conducting substance abuse research?
When it comes to tackling substance abuse, hospitals across the United States are making significant strides through their participation in cutting-edge clinical trials. In sunny Los Angeles, the University of California leads the charge with five active trials focused on substance abuse and an impressive track record of nine completed studies since their first trial in 2004. Similarly committed to addressing this critical issue is Gateway Community Services in Jacksonville, who have three ongoing substance abuse trials and have contributed to eight previous investigations since their inaugural trial in 2004.
Meanwhile, on the East Coast, Boston stands out as a hub for groundbreaking research. The Massachusetts General Hospital HOPE Clinic is currently conducting three active substance abuse trials while marking its first recorded trial in this field just last year, in 2020. This exemplifies how even recent advancements can hold great promise for those struggling with addiction. Additionally contributing to Boston's efforts is Boston Medical Center which has also embarked on three active clinical trials for substance abuse and holds a notable history of thirteen prior studies dating back to 2004.
Moreover,Pittsburgh joins these leading institutions with its Pregnancy Recovery Center at Magee-Womens Hospital of UPMC offering hope and support through three ongoing clinical trials targeting substance abuse. Their commitment shines brightly as they initiated their first recorded trial only recently alongside Massachusetts General Hospital HOPE Clinic pinning them both down as one among few pioneering research institutes dedicated entirely towards this crucial sphere starting from just two years ago,towards end of2019
These hospitals represent beacons of progress and compassion by actively seeking answers to combat one of society's most challenging issues—substance abuse.Through continuously pushing boundaries via various experimental methodologies researchers are not leaving any stone unturned each small step taken ultimately paves way towards better understanding;breeds optimism paving path towards healthier future free from such harmful dependencies not only helping individuals but societies collectively
Which are the best cities for substance abuse clinical trials?
When it comes to substance abuse clinical trials, several cities emerge as leading centers for research. Boston, Massachusetts offers 10 active trials focusing on treatments like Buprenorphine Injection and The SUPPER Project. Los Angeles, California follows closely with 9 ongoing studies examining interventions such as Contingency Management for Methamphetamine Reduction and Trauma-focused Substance Abuse Intervention. Additionally, New york, New York contributes to this field with 5 active trials investigating approaches like TMC - Digital Tutorial plus training Materials plus feedback and Coaching. These cities are joined by Baltimore, Maryland and Salt Lake City, Utah in their dedication to advancing our understanding of substance abuse treatment through rigorous clinical research.
Which are the top treatments for substance abuse being explored in clinical trials?
Clinical trials in the field of substance abuse are paving the way for innovative treatments. Buprenorphine Injection has emerged as a top contender, with three active and three all-time trials dedicated to exploring its potential. Another promising approach is Peer-Delivered Behavioral Activation, known as "Peer Activate," which is currently being evaluated in two ongoing trials after making its debut in 2022. Additionally, Repetitive Transcranial magnetic stimulation (rTMS) shows promise, with two active and two all-time substance abuse trials since first being listed in 2021. These groundbreaking treatments offer hope for individuals struggling with substance abuse disorders and signify progress towards improved outcomes.
What are the most recent clinical trials for substance abuse?
Exciting developments are occurring in the field of substance abuse treatment, with recent clinical trials offering hope for individuals struggling with addiction. One such trial explores the potential benefits of active rotigotine (RTG), a medication being studied in Phase 2 as a possible treatment option. Additionally, THC and psilocybin have shown promise in Phase 1 trials for their potential efficacy in addressing substance abuse. High-strength THC is also being investigated as a potential intervention against substance abuse. Another promising study combines standard outpatient treatment with Laddr® to enhance outcomes for those seeking help. Through these ongoing investigations, researchers aim to uncover new strategies that can make a positive impact on individuals battling substance abuse disorders.
What substance abuse clinical trials were recently completed?
Several clinical trials investigating new approaches to substance abuse have recently concluded, highlighting significant progress in this field. In August 2022, Indivior Inc. completed a trial involving INDV-2000, exploring its potential for addressing substance abuse disorders. Similarly, in March 2021, Viatris Specialty LLC finalized a trial focusing on gabapentin 1800 mg as a treatment option. Furthermore, the Medical University of South carolina successfully finished their investigation into Ketamine Hydrochloride's efficacy against substance abuse in December 2020. These recent advancements demonstrate the commitment of researchers and offer hope for individuals struggling with substance use disorders.